3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
7
Brain Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
4
Sarcoma
4
Carcinoma, Non-Small-Cell Lung
4
Solid Tumor, Adult
3
Rhabdomyosarcoma
3
Neoplasms
3
Meningioma
3
Glioma
3
Esophageal Neoplasms
3
Pituitary Neoplasms
2
Osteosarcoma
2
Nerve Sheath Neoplasms
2
Glioblastoma
2
Craniopharyngioma
2
Chordoma
2
Chondrosarcoma
2
Breast Neoplasms
2
Bone Neoplasms
2
Wilms Tumor
1
Vascular Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Solitary Fibrous Tumors
1
Solid Tumor
1
Smooth Muscle Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Resectable Lung Non-Small Cell Carcinoma
1
Recurrent Head and Neck Carcinoma
1
Interventions
Gemcitabine
33
Cisplatin
28
pembrolizumab
19
durvalumab
17
Oxaliplatin
16
Fluorouracil
16
Leucovorin
14
Magnetic Resonance Spectroscopy
13
Specimen Handling
9
Biopsy
9
lenvatinib
7
Nivolumab
7
Capecitabine
7
Taxes
6
Paclitaxel
6
Irinotecan
6
fludarabine
5
Folfox protocol
5
Drug Therapy
5
Carboplatin
5
Albumin-Bound Paclitaxel
5
pemigatinib
4
Ipilimumab
4
Fluorodeoxyglucose F18
4
Floxuridine
4
Cyclophosphamide
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
tremelimumab
3
olaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
Proton Therapy
×
1 year
×
Clear all
No trials found.